Former NIH official says Trump admin cut government's 'Safe to Sleep' team that helped reduce infant deaths
In mid-2025, rumors spread online about the potential closure of the national campaign "Safe to Sleep," which educated parents on ways to reduce the risk of sleep-related infant deaths. The National Institutes of Health launched the public education initiative in 1994 alongside several private organizations, and the program helped slash deaths attributed to sudden infant death syndrome (SIDS).
It is accurate to say that a former NIH spokesperson who worked at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the NIH institute that led Safe to Sleep, announced in April that her entire office was eliminated, effectively ending the federal government's participation in the campaign. As of this writing, Christina Stile, the spokesperson, is still listed as NICHD's public-facing contact on NIH's website.
However, NIH would not confirm this report and said "no final decisions" had been made about the future of the program. Stile told Snopes that while there is no one left at NIH to lead Safe to Sleep, she suspects NIH's statement is truthful because the Trump administration's efforts to restructure the federal government is still ongoing as of this writing.
Nonprofit organizations that collaborated on the Safe to Sleep campaign are looking to continue the program. But in an emailed update to Safe to Sleep partners from Dr. Rachel Moon, a pediatrics professor who worked on the program, Moon warned that while the American Academy of Pediatrics would "continue to be a leading voice," the organization cannot "dedicate as much time and resources as NICHD could."
In late April and early May 2025, a rumor spread online that U.S. President Donald Trump's administration fired the National Institutes of Health (NIH) team behind "Safe to Sleep," a public awareness campaign to prevent babies from dying in their sleep.
The program helped slash deaths attributed to sudden infant death syndrome (SIDS) by more than half when it first launched 30 years ago, according to the NIH and Centers for Disease Control and Prevention (CDP) data. Those rates have risen in recent years despite decreasing infant mortality, according to peer-reviewed research.
Discussion about the federal government's alleged decision circulated on Bluesky, Facebook and Reddit. Meanwhile, Snopes readers searched the website for information on whether Trump's administration eliminated the Safe to Sleep team.
It is accurate to say that according to former NIH spokesperson Christina Stile, Trump's administration eliminated the team that coordinated the Safe to Sleep campaign, effectively ending the federal government's participation in the wide-ranging public education initiative, as first reported by STAT News. However, in a statement sent via email, NIH said that "no final decision has been made regarding the future of the Safe to Sleep® campaign."
"Safe to Sleep® campaign materials and tools remain available to the public, and we encourage individuals to visit https://safetosleep.nichd.nih.gov to access these resources," NIH's statement said. When pressed to acknowledge that NIH fired the Safe to Sleep team, the agency said it was "unable to comment on personnel matters."
Stile worked at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which NIH oversees, until the White House eliminated the institute's communications office. That office led the Safe to Sleep initiative in partnership with various nonprofit organizations that shared Safe to Sleep educational resources with parents in local communities.
Stile said in a LinkedIn direct message that she suspects the agency's statement about having "no final decision" on the program's future is truthful, as the Trump administration continues to restructure the federal government.
"There is no certainty that NICHD will even exist if the NIH is reorganized, nor is it known whether its mission will include reducing infant mortality," said Stile, whose name was still on the institute's staff list webpage as of this writing.
Due to the constantly changing situation, and because NIH declined to confirm the layoffs, we are not putting a truthfulness rating on this story — but here is what we know to be true as of this writing.
White House eliminates the office in charge
Stile said officials eliminated NICHD's entire communications office on April 1.
"That action effectively ended NICHD's leadership of the campaign," Stile wrote. She said the decision "was made without warning or explanation by the administration under the purview of DOGE," or the Department of Government Efficiency. DOGE did not immediately return a request sent via X to confirm this; the department does not have a formal and public-facing media office.
The federal government first launched "Safe to Sleep" under the name "Back to Sleep" in 1994 alongside private organizations. Back then, the public awareness campaign focused specifically on reducing the risk of sudden infant death syndrome, a type of sudden unexplained death that usually occurs when the baby is asleep. (The name "Back to Sleep" came from the recommendation that healthy babies be placed on their backs.)
Deaths dropped in the years following the program — according to a 2012 news release, SIDS rates in the United States had dropped 50% since the start of the campaign; peer-reviewed research also indicates the program had a positive impact. At the same time, however, non-SIDS sleep-related infant deaths rose, leading NICHD to expand the program to address those causes as well.
"Safe to Sleep builds upon the success of the Back to Sleep campaign and includes messages about reducing the risk of SIDS and of other sleep-related causes of infant death, such as suffocation and entrapment," the 2012 release said.
"Since the campaign began, U.S. SIDS rates have dropped by 50% overall and the rate of back sleeping has increased significantly," a 2012 news release from NICHD announcing the decision said.
Ending the federal government's participation in Safe to Sleep does not necessarily mean the end of the campaign itself, at least informally — but it does mean it would require new leadership.
"I think it's possible NICHD or NIH could support Safe to Sleep through other means in the future; but, for now, there is nobody at NICHD to lead the activities," Stile told Snopes.
According to Shayna Raphael, who leads an organization raising awareness about SIDS called the Claire Bear Foundation, nonprofits formerly partnered with NICHD on Safe to Sleep are in discussions with each other regarding how to continue "the best version" possible of the campaign without participation from the federal government. In an email forwarded to Snopes by Raphael, Dr. Rachel Moon, a pediatrics professor who collaborated on the campaign, said staff members from the American Academy of Pediatrics (AAP) and First Candle, two organizations that co-founded the initial campaign with NICHD, met and "unanimously agreed that the Safe to Sleep campaign should continue."
"The AAP will continue to be a leading voice in the campaign as resources and priorities allow within the evolving context of child health, safety, and wellness," Moon wrote. "However, it should be understood by all that the AAP will not be able to dedicate as much time and resources as NICHD could."
Moon added that staff at First Candle volunteered to schedule the quarterly Safe to Sleep campaign partner meetings once led by NICHD, and that AAP would welcome "new partners who may be interested in taking a lead role." Snopes reached out to AAP to verify the information in Moon's email was accurate and up-to-date and await a response.
In sum, it appears the program will likely continue, with or without the federal government's help — but as of this writing, the Trump administration appears to have terminated support of the Safe to Sleep campaign.
Sources:
Belkoura, Ismael M. "NIH Cancels Participation in Safe to Sleep Campaign That Decreased Infant Deaths." Statnews.com, STAT, 30 Apr. 2025, www.statnews.com/2025/04/30/nih-ends-participation-in-safe-to-sleep-campaign-to-prevent-infant-deaths/. Accessed 6 May 2025.
"Campaign History | Safe to Sleep®." Https://Safetosleep.nichd.nih.gov/, safetosleep.nichd.nih.gov/campaign/history. Accessed 6 May 2025.
"Contacts." National Institutes of Health (NIH), 11 May 2015, www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/clear-communication/plain-language/contacts. Accessed 6 May 2025.
"Contacts | National Institutes of Health (NIH)." Archive.ph, 6 May 2025, archive.ph/R3kwH. Accessed 6 May 2025.
Deng, Grace. "Trump's First 100 Days: 25 Rumors We've Investigated." Snopes, 29 Apr. 2025, www.snopes.com/collections/trump-first-100-days-collection/. Accessed 6 May 2025.
"Homepage | Safe to Sleep." Nih.gov, National Institutes of Health, safetosleep.nichd.nih.gov/. Accessed 6 May 2025.
"NICHD and Its Collaborators Launch Expanded Infant Mortality Awareness Campaign." Https://Www.nichd.nih.gov/, 3 Oct. 2012, www.nichd.nih.gov/newsroom/resources/spotlight/100312-safe-to-sleep. Accessed 6 May 2025.
Rodgers, Linda. "Amid Decreasing Infant Mortality, Sleep-Related Infant Deaths Are on the Rise." JAMA, Mar. 2025, https://doi.org/10.1001/jama.2025.1345. Accessed 16 Mar. 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
Medicaid churn: How working Americans could mistakenly lose coverage under Trump tax bill
Medicaid churn: How working Americans could mistakenly lose coverage under Trump tax bill Show Caption Hide Caption President Trump gives his thoughts on Elon Musk amid clash on bill President Donald Trump responded to Elon Musk's criticism of his "big, beautiful bill" with disappointment as Musk responded on X. A centerpiece of Donald Trump's tax bill would make millions of Medicaid recipients work, volunteer or study to maintain their publicly-financed health insurance. Republicans say the work requirement is vital to protect taxpayers while motivating nondisabled Medicaid recipients to take charge of their physical and fiscal health. Dr. Mehmet Oz challenged this population to "prove that you matter." But health advocacy groups and analysts say most recipients already work in jobs that don't provide affordable health insurance or pay enough for people to afford their own insurance. They say mandating a Medicaid work requirement − combined with more frequent eligibility checks − would create an administrative nightmare that drops coverage for many who qualify for the public health insurance program for low-income and disabled residents. What is Medicaid churn? Medicaid rolls vary from month to month as people lose eligibility due to a new job, a raise or other income source that disqualifies them for coverage. A job loss or change in life circumstances could make someone newly eligible. The constant change of Medicaid rolls is what health policy experts call churn. A person who temporarily loses coverage due to a paperwork issue or mistake then must again sign up. "Churn is what happens when these eligibility systems become difficult to navigate," said Jennifer Tolbert, deputy director of the program on Medicaid and the uninsured for KFF, a health policy nonprofit. The federal government requires state Medicaid programs to check enrollees eligibility once a year. The Trump tax cut legislation would mandate states double eligibility checks to twice a year. And states would have the added duty of verifying a person's employment or exemption status. The legislation, which passed the House and awaits Senate approval, mandates Medicaid recipients who are "able-bodied" adults without children work 80 hours per month or qualify for an exemption such as being a student, caregiver or having a disability. The bill defines able-bodied as people who are not medically certified as physically or unfit for employment. The legislation also would strip coverage from undocumented immigrants who get Medicaid through state-funded programs. Health policy experts say more frequent eligibility checks and red tape will add administrative costs and cut off people who qualify but fall through the cracks due to administrative miscues. "People are going to have to document work status or exemption status multiple times a year, and at each point there's a risk that someone who is eligible could lose coverage," Tolbert said. Thousands lost coverage under Arkansas work requirement During the first Trump administration, the Centers for Medicare & Medicaid Services gave states the option of implementing a work requirement for nondisabled adults on Medicaid. Arkansas' work requirement cut more than 18,000 residents from Medicaid within the first seven months of the program. People were removed often because people were unaware of paperwork requirements to keep their coverage, research shows and analysts said. In April, a study by researchers from the Urban Institute and Loyola University Chicago found the Arkansas uninsured rate jumped 7.4 percentage points among low-income adults age 30 to 49 after the state's work requirement began. The policy's impact on employment among that age group was "negative, small and statistically insignificant," the study said. Arkansas adults who didn't have access to the internet at home were disproportionately harmed by the policy, a sign adults might've had trouble accessing the state's online portal to report work histories or exemptions, the Urban Institute said. If the work requirement for Medicaid recipients is adopted nationwide, health experts say millions of working poor Americans will inevitably lose coverage. The nonpartisan Congressional Budget Office estimated 10.9 million Americans would lose health insurance coverage through 2034 under the legislation. Most would lose coverage due to the Medicaid work requirement and the twice-a-year eligibility checks, but about 3.1 million would become uninsured from tweaks to Affordable Care Act enrollment, according to a KFF analysis. The ranks of the uninsured could grow larger if Congress doesn't extend the COVID-19 pandemic-era tax credits that have made ACA plans more affordable for consumers. If the tax credits expire and Congress passes the current version of the Trump tax bill, as many as 16 million Americans would lose coverage , according to CBO. "Coverage loss from work requirements should actually be very small," said Kathy Hempstead, a senior policy officer at the Robert Wood Johnson Foundation. "But we anticipate it will be very large, because people will not be able to comply with the requirements and will lose their coverage." Dr. Oz: Medicaid spending is 'crippling the system' The Trump administration's top Medicaid official has defended the House legislation as a necessary step to slow spending for the federal health program that covers nearly 80 million low-income and disabled Americans. In a June 4 interview with Fox Business, Dr. Oz challenged Medicaid recipients who would face work requirements should "prove that you matter." Oz, the Trump-appointed administrator of the Centers for Medicare & Medicaid Services, said the work requirement asks "able-bodied individuals who are able to go back to work at least try to get a job or volunteer or take care of a loved one who needs help or go back into school. Do something to show you have agency over your future." In a Fox News interview posted on the social media site X, Oz said Medicaid spending has surged 50% since 2019, a pace that is "crippling the system." However, some Republicans have pushed back on the proposed cuts. In a May opinion piece in the New York Times, Sen. Josh Hawley, R- Missouri, said "slashing health insurance for the working poor" is "morally wrong and politically suicidal." Survey: Americans worried about Medicaid cuts The public is paying attention to the proposed Medicaid cuts. Slightly more than half of adults said they're worried significant cuts in Medicaid spending would negatively affect their family's ability to obtain and afford health care, according to a KFF health tracking poll released June 6. The survey this survey of 2,539 U.S. adults was conducted online and by telephone over three weeks in May. The survey said nearly 6 in 10 adults said the Trump administration's policies would weaken Medicaid, but there is a stark divide based on party affiliation. Nine in 10 Democrats but just 2 in 10 Republicans expect the administration's policies would weaken Medicaid. Republicans also were far more likely than Democrats to say that the Trump's policies would strengthen Medicaid. Still, while the survey suggests people are tracking the news, many likely wouldn't know whether their coverage has changed until they try to get medical care. "People don't often know that they've lost coverage until they try and fill a prescription or see a doctor," Tolbert said.
Business Upturn
3 hours ago
- Business Upturn
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV VLP in children 2 to 11 years of age. This first trial of CHIKV VLP in a pediatric population aims to expand the target population for the vaccine, currently approved for persons 12 years of age and older in the US, EU and United Kingdom under the trade name VIMKUNYA®. The global, randomized, double-blind, placebo-controlled study (NCT07003984), sponsored by Bavarian Nordic, will evaluate the safety and immunogenicity of CHIK VLP vaccine in 720 children 2 to 11 years of age for two years. Primary results from the study are anticipated in the first half of 2028. Paul Chaplin, President & CEO of Bavarian Nordic, said: 'Upon the successful approvals earlier this year of our chikungunya vaccine for persons aged 12 and older, we are pleased to initiate this Phase 3 study in children for whom there are currently no vaccines available to prevent against chikungunya. This study represents a significant part of our commitment to the further development of the vaccine to help ensure access for people of all ages.' About VIMKUNYA® Chikungunya vaccine (recombinant, adsorbed) VIMKUNYA (CHIKV VLP) is the first and only virus-like particle (VLP) vaccine for the prevention of chikungunya disease in individuals aged 12 years and above. It is designed to induce a robust seroresponse, with protective immunity starting to develop as early as 1 week after vaccination. VIMKUNYA is the only single-dose vaccine against chikungunya disease available in a prefilled syringe. VIMKUNYA does not contain viral genetic material and is therefore non-infectious and unable to cause disease, ensuring a broad range of people can benefit from vaccination. The vaccine was approved by the U.S. Food and Drug Administration (FDA) and the European Commission in February 20251,2 and the United Kingdom in May 20253. The US, EU and UK approvals of VIMKUNYA (CHIKV VLP vaccine) were all based on results from two phase 3 clinical trials which enrolled more than 3,500 healthy individuals 12 years of age and older. The studies met their primary endpoints, with results showing that 21 days after vaccination, the vaccine induced neutralizing antibodies in up to 97.8% of the vaccinated individuals, (97.8% in individuals 12 years to 64 and 87.3% in over 65-year-olds). The key secondary endpoint of seroresponse rate at day 8 post vaccination was 46.6% and 96.8% at day 15 in the 12–64-year-old population and 82.3% at day 15 for the over 65 population. The vaccine was well-tolerated and vaccine-related adverse events were mainly mild or moderate in nature. The most common side effects were pain at the injection site, fatigue, headache, and muscle pain4,5. About chikungunya Chikungunya is a mosquito-borne disease caused by the chikungunya virus (CHIKV). In the past 20 years, the virus has emerged across several regions in Asia, Africa, and the Americas, including many popular travel destinations, often causing large unpredictable outbreaks. Since its discovery, CHIKV has been identified in more than 110 countries, with evidence of transmission confirmed in more than 50 countries over the past five years6. Chikungunya typically presents with acute symptoms, including fever, rash, fatigue, headache, and often severe and incapacitating joint pain. Most patients recover within 1-2 weeks, but 30-40% of those affected may develop chronic arthritis that can last for months or even years7. In 2024, 620,000 cases of chikungunya and over 200 deaths were reported worldwide8. Recent data suggest that chikungunya is severely underreported and often misdiagnosed as dengue fever due to a similar symptom profile9. About Bavarian Nordic Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit Forward-looking statements This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law. Contact investors: Europe: Rolf Sass Sørensen, Vice President Investor Relations, [email protected], Tel: +45 61 77 47 43 US: Graham Morrell, Paddock Circle Advisors, [email protected], Tel: +1 781 686 9600 Contact media: Nicole Seroff, Vice President Corporate Communications, [email protected], Tel: +45 53 88 06 03 1 Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older. 2 Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older. 3 Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United Kingdom. 4 Richardson JS, et al. Chikungunya Virus VLP Vaccine: Phase 3 Trial in Adolescents and Adults. medRxiv 2024.10.11.24315179. 5 Tindale LC, et al. Chikungunya Virus VLP Vaccine: Phase 3 Trial in Adults ≥65 Years of Age. medRxiv 2024.10.10.24315205. 6 Centers for Disease Control and Prevention. Areas at Risk for Chikungunya. 7 European Centre for Disease Prevention and Control. Chikungunya virus disease. 8 European Centre for Disease Prevention and Control. Chikungunya virus disease case notification rate per 100 000 population, January 2024-December 2024. 9 Ribas Freitas AR, Pinheiro Chagas AA, Siqueira AM, Pamplona de Góes Cavalcanti L. How much of the current serious arbovirus epidemic in Brazil is dengue and how much is chikungunya? Lancet Reg Health Am. 2024 Apr 30;34:100753. doi: 10.1016/ PMID: 38711542; PMCID: PMC11070701. Attachment Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Yahoo
5 hours ago
- Yahoo
Trump Admin Brings Back Hundreds of CDC Staffers it Previously Fired
The Trump administration is reversing its decision to fire hundreds of staffers from the Centers for Disease Control and Prevention (CDC) in a humiliating about-turn. A spokesperson for the Department of Health and Human Services (HHS) told STAT that the CDC will be bringing back more than 450 employees that were fired in an attempt to reorganize the agency. Some of the departments that will be reinstating employees are: The National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; the Global Health Center; the National Center for Environmental Health; the Immediate Office of the Director. These divisions helped track and prevent HIV, prevent lead poisoning in children, as well as ensure that cruise lines were safe from disease. HHS, which also oversees the CDC, first announced this 'dramatic restructuring' in March, saying that they would downsize from 82,000 to 62,000 full-time employees, claiming that it would 'save taxpayers $1.8 billion per year.' The department also revealed that it would be creating a new division called the Administration for a Healthy America (AHA), which would be led by HHS Secretary Robert F. Kennedy Jr. 'We aren't just reducing bureaucratic sprawl. We are realigning the organization with its core mission and our new priorities in reversing the chronic disease epidemic,' Kennedy said. 'This Department will do more—a lot more—at a lower cost to the taxpayer,' he claimed. He reaffirmed this sentiment in an X post in March, noting that these cuts would help eliminate the current 'alphabet soup of departments.' 'We are streamlining HHS to make our agency more efficient and more effective. We will eliminate an entire alphabet soup of departments,' he said. As a result, around 10,000 employees were fired under the guidance of Elon Musk's Department of Government Efficiency (DOGE). Yet Kennedy has already backtracked on these sweeping federal layoffs, admitting in April that too many cuts were made in the effort to 'Make America Healthy Again,' though he said that 'was always the plan.' 'We're streamlining the agencies. We're going to make it work for public health, make it work for the American people. In the course of that, there were a number of instances where studies that should have not have been cut were cut, and we've reinstated them,' Kennedy said. 'Personnel that should not have been cut were cut—we're reinstating them, and that was always the plan,' he stated.
